F
Franco M. Recchia
Researcher at Vanderbilt University
Publications - 54
Citations - 2000
Franco M. Recchia is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Visual acuity & Vitrectomy. The author has an hindex of 22, co-authored 52 publications receiving 1872 citations. Previous affiliations of Franco M. Recchia include Vanderbilt University Medical Center & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
Donald S. Fong,Samara F. Strauber,Lloyd Paul Aiello,Roy W. Beck,David Callanan,Ronald P. Danis,Matthew D. Davis,Stephen S. Feman,Frederick L. Ferris,Scott M. Friedman,Charles A. Garcia,Adam R. Glassman,Dennis P. Han,Darma Le,Craig Kollman,Andreas K. Lauer,Franco M. Recchia,Sharon D. Solomon +17 more
TL;DR: At 12 months after treatment, the MMG technique was less effective at reducing optical coherence tomography-measured retinal thickening than the more extensively evaluated current modified ETDRS laser photocoagulation approach; however, the visual acuity outcome with both approaches is not substantially different.
Journal ArticleDOI
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.
Michael S. Ip,Ingrid U. Scott,Gary C. Brown,Melissa M. Brown,Allen C. Ho,Suber S. Huang,Franco M. Recchia +6 more
TL;DR: Review of the available literature to date suggests that anti-VEGF pharmacotherapy, delivered by intravitreal injection, is a safe and effective treatment for neovascular AMD for up to 2 years.
Journal ArticleDOI
Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology
TL;DR: The technological advances of small-gauge vitrectomy seem to afford visual benefit comparable with that seen with traditional 20- gauge surgery, with more rapid healing, less discomfort, and an acceptably low incidence of adverse events comparable with those observed with conventional 20-g Gauge Vitrectomy.
Journal ArticleDOI
Changing trends in the microbiologic aspects of postcataract endophthalmitis.
Franco M. Recchia,Brandon G. Busbee,Robert B Pearlman,Cynthia A. Carvalho-Recchia,Allen C. Ho +4 more
TL;DR: The spectrum of pathogens causing postcataract endophthalmitis is changing, and resistance to antibiotics used for its prophylaxis has grown, and these findings may affect the empirical treatment of post Cataract Endophthalmits, as well as the use and choice of antibiotics in patients undergoing cataract surgery.
Journal ArticleDOI
Bleb-associated endophthalmitis : clinical characteristics and visual outcomes
Brandon G. Busbee,Franco M. Recchia,Richard S. Kaiser,Parveen K. Nagra,Brett J. Rosenblatt,Robert B Pearlman +5 more
TL;DR: B bleb-associated endophthalmitis causes significant visual morbidity and patients with culture-negative BAE and patients treated with prompt PPV may achieve better visual outcome.